Parkman Healthcare Partners’s Cooper Companies COO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.43M Sell
89,883
-35,452
-28% -$2.8M 0.66% 50
2025
Q4
$10.3M Sell
125,335
-51,188
-29% -$3.83M 0.98% 38
2025
Q3
$12.1M Sell
176,523
-208,956
-54% -$14.8M 1.26% 29
2025
Q2
$27.4M Buy
385,479
+72,829
+23% +$5.58M 3.15% 6
2025
Q1
$26.4M Buy
312,650
+38,081
+14% +$3.41M 3.13% 7
2024
Q4
$25.2M Sell
274,569
-18,024
-6% -$1.84M 3.36% 6
2024
Q3
$32.3M Sell
292,593
-15,805
-5% -$1.54M 4.12% 4
2024
Q2
$26.9M Buy
308,398
+22,999
+8% +$2.15M 3.61% 5
2024
Q1
$29M Sell
285,399
-15,333
-5% -$1.48M 3.55% 4
2023
Q4
$28.5M Buy
300,732
+39,448
+15% +$3.31M 4.01% 3
2023
Q3
$20.8M Buy
261,284
+100,792
+63% +$9.29M 3.81% 5
2023
Q2
$15.4M Sell
160,492
-49,044
-23% -$4.6M 2.67% 10
2023
Q1
$19.6M Buy
209,536
+169,536
+424% +$14.6M 4.25% 4
2022
Q4
$3.31M Sell
40,000
-2,488
-6% -$184K 0.88% 44
2022
Q3
$2.8M Buy
42,488
+488
+1% +$37.4K 0.8% 48
2022
Q2
$3.29M Sell
42,000
-36,340
-46% -$3.22M 1.21% 25
2022
Q1
$8.18M Sell
78,340
-16,520
-17% -$1.66M 2.39% 16
2021
Q4
$9.94M Sell
94,860
-1,492
-2% -$152K 2.19% 16
2021
Q3
$9.96M Buy
96,352
+22,000
+30% +$2.35M 2.52% 11
2021
Q2
$7.37M Buy
74,352
+44,352
+148% +$4.35M 1.61% 20
2021
Q1
$2.88M Buy
+30,000
New +$2.85M 0.67% 46

Other funds holding COO

Parkman Healthcare Partners's COO Position: Q1 2026 in Review

Parkman Healthcare Partners reduced its Cooper Companies (COO) stake by 28% in Q1 2026, selling an estimated $2.8M and leaving 89,883 shares worth $6.43M. The position accounts for 0.66% of the portfolio, ranked #50.

Parkman Healthcare Partners first reported a position in COO in Q1 2021 and has held it in 21 quarters since. The position peaked at $32.3M in Q3 2024. 675 funds tracked by Wall St. Rank hold COO as of Q1 2026.

  • Parkman Healthcare Partners held 89,883 shares of Cooper Companies worth $6.43M as of Q1 2026.
  • Parkman Healthcare Partners sold 35,452 Cooper Companies shares in Q1 2026, an estimated $2.8M.
  • Cooper Companies made up 0.66% of Parkman Healthcare Partners's portfolio in Q1 2026, its #50 holding.
  • Parkman Healthcare Partners first reported a position in Cooper Companies in Q1 2021 and has held it in 21 quarters since.
  • Parkman Healthcare Partners's Cooper Companies position peaked at $32.3M in Q3 2024.
  • 675 funds tracked by Wall St. Rank held Cooper Companies as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.